Novel antitumor 2-cyanoaziridine-1-carboxamides

Bhashyam S. Iyengar, Robert T. Dorr, David S. Alberts, Evan M. Hersh, Sydney E. Salmon, William A. Remers

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


A set of 20 2-cyanoaziridine-1-carboxamides was synthesized from 2- cyanoaziridine and appropriate isocyanates. These compounds were active against a variety of solid and hematological tumor cells in culture, including strains resistant to doxorubicin and mitoxantrone. Their potencies in these assays correlated with the lipophilicity of substituents. The N- phenyl derivative was more potent and equally effective to imexon, a cyclized 2-cyanoaziridine-1-carboxamide of clinical interest, against cloned fresh human tumors.

Original languageEnglish (US)
Pages (from-to)510-514
Number of pages5
JournalJournal of Medicinal Chemistry
Issue number3
StatePublished - Feb 24 1999

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Novel antitumor 2-cyanoaziridine-1-carboxamides'. Together they form a unique fingerprint.

Cite this